A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma

Advances in Experimental Medicine and Biology

Volumn 815, Issue , 2015, Pages 333-348

  Shrotriya, Sangeeta ^a   Agarwal, Rajesh ^a,b   Sclafani, Robert A ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHECKPOINT KINASE 1; CYCLOOXYGENASE 2; DNA POLYMERASE; DNA TOPOISOMERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; TELOMERASE; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CARCINOGEN DNA INTERACTION; CELLULAR STRESS RESPONSE; DNA BINDING; DNA DRUG COMPLEX; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; GENE INTERACTION; GENETIC PREDISPOSITION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEART PROTECTION; HUMAN; MOLECULAR PATHOLOGY; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RED WINE; RNA BINDING; TUMOR SUPPRESSOR GENE; CARCINOMA, SQUAMOUS CELL; CHEMOPROPHYLAXIS; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM;

VITACEAE;

ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; ETHANOL; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; STILBENES;

EID: 84925321855     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09614-8_19     Document Type: Article

References (72)

1. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71(10):1397–1421
2. Balbo S, Meng L et al (2012) Kinetics of DNA adduct formation in the oral cavity after drinking alcohol. Cancer Epidemiol Biomarkers Prev 21(4):601–608
3. Basso E, Fiore M et al (2013) Effects of resveratrol on topoisomerase II-alpha activity: induction of micronuclei and inhibition of chromosome segregation in CHO-K1 cells. Mutagenesis 28(3):243–248
4. Bo S, Ciccone G et al (2013) Anti-infl ammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20(10):1323–1331
5. Brown GC, Borutaite V (2011) There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion 12(1):1–4
6. Buonocore D, Lazzeretti A et al (2012) Resveratrol-procyanidin blend: nutraceutical and anti-aging effi cacy evaluated in a placebocontrolled, double-blind study. Clin Cosmet Investig Dermatol 5:159–165
7. Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87(1):14–32
8. Connell PP, Jayathilaka K et al (2006) Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol 28(5):1113–1119
9. Cui R, Kamatani Y et al (2009) Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137(5): 1768–1775
10. Day GL, Blot WJ et al (1994) Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 86(2):131–137
11. De Groote D, Van Belleghem K et al (2012) Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects. Ann Nutr Metab 61(1):15–24
12. Derry MM, Raina K et al (2013) Identifying molecular targets of lifestyle modifi cations in colon cancer prevention. Front Oncol 3:119
13. Dudek AZ, Lesniewski-Kmak K et al (2009) Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor. Br J Cancer 100(9):1379–1384
14. Ferlay J, Shin HR et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
15. Fortune JM, Osheroff N (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 64:221–253
16. Fouret P, Monceaux G et al (1997) Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 123(5):513–516
17. Freedman ND, Schatzkin A et al (2007) Alcohol and head and neck cancer risk in a prospective study. Br J Cancer 96(9):1469–1474
18. Freudlsperger C, Burnett JR et al (2010) EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opin Ther Targets 15(1):63–74
19. Furgason JM, Bahassi M et al (2012) Targeting DNA repair mechanisms in cancer. Pharmacol Ther 137(3):298–308
20. Garaycoechea JI, Crossan GP et al (2012) Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489(7417):571–575
21. Gatz SA, Wiesmuller L (2008) Take a break—resveratrol in action on DNA. Carcinogenesis 29(2):321–332
22. Gillison ML, Koch WM et al (2000) Evidence for a causal association between human papil-lomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720
23. Hira A, Yabe H et al (2013) Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 122(18):3206–3209
24. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366–374
25. Hong WK, Endicott J et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315(24):1501–1505
26. Howard JD, Lu B et al (2012) Therapeutic targets in head and neck squamous cell carcinoma: identifi cation, evaluation, and clinical translation. Oral Oncol 48(1):10–17
27. Howells LM, Berry DP et al (2011) Phase I randomized, double-blind pilot study of micron-ized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 4(9):1419–1425
28. Irish JC, Bernstein A (1993) Oncogenes in head and neck cancer. Laryngoscope 103(1 Pt 1): 42–52
29. Ishiji T (2000) Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 27(2):73–86
30. Jelski W, Kutylowska E et al (2011) Alcohol dehydrogenase (ADH) and aldehyde dehydroge-nase (ALDH) as candidates for tumor markers in patients with pancreatic cancer. J Gastrointestin Liver Dis 20(3):255–259
31. Kundu SK, Nestor M (2012) Targeted therapy in head and neck cancer. Tumour Biol 33(3):707–721
32. Lachenmeier DW, Monakhova YB (2011) Short-term salivary acetaldehyde increase due to direct exposure to alcoholic beverages as an additional cancer risk factor beyond ethanol metabolism. J Exp Clin Cancer Res 30:3
33. Lanzilli G, Fuggetta MP et al (2006) Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol 28(3):641–648
34. Leemans CR, Braakhuis BJ et al (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22
35. Lenaz G (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52(3–5):159–164
36. Leon-Galicia I, Diaz-Chavez J et al (2013) Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. Eur J Cancer Prev 22(1):11–20
37. Maacke H, Opitz S et al (2000) Over-expression of wild-type Rad51 correlates with histologi-cal grading of invasive ductal breast cancer. Int J Cancer 88(6):907–913
38. Maiorano D, Lutzmann M et al (2006) MCM proteins and DNA replication. Curr Opin Cell Biol 18(2):130–136
39. Markus MA, Marques FZ et al (2011) Resveratrol, by modulating RNA processing factor levels, can infl uence the alternative splicing of pre-mRNAs. PLoS One 6(12):e28926
40. Martins LA, Coelho BP et al (2014) Resveratrol induces pro-oxidant effects and time-dependent resistance to cytotoxicity in activated hepatic stellate cells. Cell Biochem Biophys 68(2):247–257
41. Mitra A, Jameson C et al (2009) Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology 55(6):696–704
42. Nassiri-Asl M, Hosseinzadeh H (2009) Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds. Phytother Res 23(9):1197–1204
43. Nguyen SA, Walker D et al (2012) mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol 13(1):71–81
44. O’Neil N, Rose A (2006) DNA repair. WormBook, 1–12
45. Ohba S, Fujii H et al (2009) Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. J Oral Pathol Med 39(1):74–78
46. Paglin S, Hollister T et al (2001) A novel response of cancer cells to radiation involves autoph-agy and formation of acidic vesicles. Cancer Res 61(2):439–444
47. Pavlov YI, Shcherbakova PV et al (2006) Roles of DNA polymerases in replication, repair, and recombination in eukaryotes. Int Rev Cytol 255:41–132
48. Petti S (2009) Lifestyle risk factors for oral cancer. Oral Oncol 45(4–5):340–350
49. Poeta ML, Manola J et al (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357(25):2552–2561
50. Radhakrishnan S, Reddivari L et al (2011) Resveratrol potentiates grape seed extract induced human colon cancer cell apoptosis. Front Biosci (Elite Ed) 3:1509–1523
51. Radojicic J, Zaravinos A et al (2012) HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. Int J Biol Markers 27(1):1–12
52. Rakoff-Nahoum S (2006) Why cancer and infl ammation? Yale J Biol Med 79(3–4):123–130
53. Roy S, Kaur M et al (2007) p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther 6(10):2696–2707
54. Rusin P, Olszewski J et al (2009) Comparative study of DNA damage and repair in head and neck cancer after radiation treatment. Cell Biol Int 33(3):357–363
55. Sanchez-Alvarez R, Martinez-Outschoorn UE et al (2013) Ethanol exposure induces the cancer-associated fi broblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle 12(2):289–301
56. Sankaranarayanan R, Masuyer E et al (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18(6B):4779–4786
57. Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7(8):599–612
58. Sharafi nski ME, Ferris RL et al (2010) Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32(10):1412–1421
59. Siegel R, Naishadham D et al (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
60. Signorelli P, Ghidoni R (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16(8):449–466
61. Smith J, Tho LM et al (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108:73–112
62. Tome-Carneiro J, Larrosa M et al (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19(34):6064–6093
63. Trachootham D, Alexandre J et al (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591
64. Tsao AS, Garden AS et al (2006) Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol 24(25):4163–4169
65. Turati F, Garavello W et al (2010) A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: results by subsites. Oral Oncol 46(10):720–726
66. Tyagi A, Gu M et al (2011) Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its effi cacy against human head and neck squamous cell carcinoma. Clin Cancer Res 17(16):5402–5411
67. Tyagi A, Singh RP et al (2005) Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26(11):1978–1987
68. Wang M, Chu H et al (2013) Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J Biomed Res 27(3):179–192
69. Weng CJ, Yen GC (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38(1):76–87
70. Woutersen RA, Appelman LM et al (1986) Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology 41(2):213–231
71. Yokoyama A, Muramatsu T et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19(8):1383–1387
72. Chow, H. H., L. L. Garland, et al. (2010). “Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.” Cancer Prev Res (Phila) 3(9): 1168–1175